Effect of potentiated antibodies to cyclophosphamide on the development of tumors and effectiveness of cytostatic therapy under experimental conditions.
Antibodies to cyclophosphamide obtained by homeopathic potentiation and administered in ultralow doses exhibit no antiblastic activity and did not modulate the effectiveness of cyclophosphamide during antitumor therapy of animals with transplanted tumors (Lewis lung carcinoma and Ehrlich adenocarcinoma).
Amosova
E N
EN
Institute of Pharmacology, Tomsk Research Center, Siberian Division of the Russian Academy of Medical Sciences.
Zueva
E P
EP
Razina
T G
TG
Krylova
S G
SG
Shilova
N V
NV
Epstein
O I
OI
D000818:Animals; D000906:Antibodies / Q000276:immunology / Q000627:therapeutic use*; D018906:Antineoplastic Agents, Alkylating / Q000627:therapeutic use*; D002286:Carcinoma, Ehrlich Tumor / Q000188:drug therapy*; D018827:Carcinoma, Lewis Lung / Q000188:drug therapy*; D003520:Cyclophosphamide / Q000276:immunology* / Q000627:therapeutic use*; D054697:Cytostatic Agents / Q000627:therapeutic use*; D004305:Dose-Response Relationship, Drug; D051379:Mice; D008810:Mice, Inbred C57BL; D009374:Neoplasms, Experimental / Q000188:drug therapy
D000906:Antibodies; D018906:Antineoplastic Agents, Alkylating; D054697:Cytostatic Agents; D003520:Cyclophosphamide